Skip to main content
Liaison International

Centralized Drug Screening Program

This page applies to: PharmCAS

The American Association of Colleges of Pharmacy (AACP) recommends that all US pharmacy schools procure a drug screening upon your initial, conditional acceptance to a pharmacy degree program. The rationale for performing drug screenings on accepted pharmacy degree program applicants is based on a number of issues, including 1) the need to enhance the safety and well-being of patients and, in so doing, to bolster the public’s continuing trust in the pharmacy profession, and 2) to ascertain the ability of accepted applicants to complete their pharmacy education and eventually become licensed pharmacists.

In support of this recommendation, AACP has initiated a PharmCAS-facilitated drug screening service, through which Certiphi Screening, Inc. (a Vertical Screen® Company) will procure a drug screening report on applicants at the point of acceptance. AACP has initiated this new service in order to recognize the desire of pharmacy degree programs to procure appropriate drug screen reports, and to prevent applicants from paying additional fees at each pharmacy degree program to which they are accepted.

Process

Certiphi uses urine screening methodologies that utilize both laboratory and instant testing technologies. Tests are performed through Certiphi’s vast pool of more than 8,000 collection sites located throughout the United States and Canada.

Once a participating degree program has offered you admission, Certiphi will send you an email with instructions for completing the drug screen and a toll-free telephone number to call with any questions. The email will provide you with access to a secure, online form where you will provide basic identifying information, consent for this report to be procured, and payment. Your consent will serve for all pharmacy degree programs, and you will not be asked to provide consent upon receiving additional, conditional acceptance offers by participating pharmacy degree programs.

After you provide payment, Certiphi will provide additional instructions on available drug screening collection facilities to be used for specimen collection. Upon report completion, Certiphi will send an email notifying you that your drug screening report is complete. A copy of the report will also be provided immediately to the pharmacy degree program(s). The report will not be released to any party other than the pharmacy degree programs requesting this report.

In the event the specimen is found positive for one or more of the drugs tested, you will receive a telephone call from the Medical Review Officer (MRO) at Certiphi. The MRO will consult with you and your physician to obtain proof as to why the drug/medication was in your specimen. If you do not return the MRO's call within three business days, the report will be delivered as a "positive" drug screening. 

Individual pharmacy degree programs may require you to submit to additional drug screenings following the initial screen.

Participating Programs

The following pharmacy degree programs participate in the Centralized Drug Screening Program.

  • Belmont University
  • California Health Sciences University
  • Campbell University
  • Chapman University
  • Chicago State University
  • Husson University
  • Keck Graduate Institute
  • LECOM – Bradenton Campus
  • LECOM – Distance Education Pathway
  • LECOM – Erie Campus
  • Larkin Health Sciences Institute
  • Long Island University
  • Marshall B. Ketchum University
  • Mercer University
  • Pacific University Oregon
  • Palm Beach Atlantic University
  • Philadelphia College of Osteopathic Medicine
  • Roosevelt University
  • Rosalind Franklin University of Medicine and Science
  • South College (TN)
  • The University of Texas at Austin
  • The University of Texas at Tyler
  • University of Kentucky
  • University of Saint Joseph
  • University of South Florida
  • University of the Pacific
  • Was this article helpful?